DFine Signs Distributor Agreements in Italy and Morocco

Share this story with your network

SAN JOSE, Calif.–(BUSINESS WIRE)–DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the signing of two distribution agreements. Siad Healthcare and Reflexion Pharma will represent DFine’s StabiliT® Vertebral Augmentation System in Italy and Morocco, respectively. Expansion into four additional countries within Europe and the Middle East are scheduled in the second half of 2010.

“Italy is a significant market for vertebral augmentation and we are pleased to partner with an established distributor, such as Siad Healthcare, to help us continue our European expansion,” said Kevin Mosher, Chief Executive Officer of DFine, Inc. “Adding Morocco, along with several additional countries planned for later this year, enables us to continue to expand the company’s global footprint and unique market position as the technology leader in the treatment of vertebral pathologies.”

DFine’s StabiliT® Vertebral Augmentation System is now commercially available on four continents in 12 countries within North America, Europe, the Middle East, Africa and Latin America. Plans to expand further in Latin America and Canada are scheduled for the fourth quarter of 2010.

About DFine

DFine, Inc., a privately held medical device company based in San Jose, Calif., is dedicated to improving patient quality of life through the development of innovative, minimally invasive therapeutic devices used to treat pathologies of the vertebrae. RF Kyphoplasty with the StabiliT® Vertebral Augmentation System is DFine’s flagship product line providing physicians greater control in the treatment of vertebral compression fractures through site and size specific cavity creation and an ultra high viscosity bone cement over an extended working time using a remotely controlled delivery system to stabilize the fracture, relieve pain and improve patient quality of life. For more information, visit www.dfineinc.com.

Leave a Comment

Your email address will not be published. Required fields are marked *

*